BLGO — BIOLARGO, INC.
—
OTC ·
Materials ·
Chemicals ·
CIK 880242 ·
Last close
$0.09
Market Cap
$27.94M
52W High
$0.20
52W Low
$0.08
ADV30
449,052
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,248,000 | 675,000 | -3,728,000 | -2,767,000 | 6,669,000 | 2,188,000 | 9,399,000 |
| Mar 2026 | 1,115,000 | 458,000 | -3,204,000 | -2,286,000 | 8,565,000 | 4,122,000 | 8,752,000 |
| Dec 2025 | 617,000 | 128,000 | -3,997,000 | -2,953,000 | 8,311,000 | 3,883,000 | 6,785,000 |
| Sep 2025 | 1,103,000 | 372,000 | -7,180,000 | -6,479,000 | 9,130,000 | 4,546,000 | 5,915,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,384,000
Investing CF
$403,000
Financing CF
$10,545,000
CapEx
$-45,000
Dividends Paid
—
Buybacks
$-15,000
EPS Diluted TTM
$-0.03
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-163,566,000
Inventory
$292,000
Receivables
$730,000
ST Investments
—
EBIT TTM
$-16,073,000
Pretax Income TTM
$-16,673,000
Interest Exp TTM
$600,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,082,000
EBITDA
$-17,951,000
Free Cash Flow
$-2,739,250
Enterprise Value
$35,790,220
Total Cash
$2,188,000
Total Debt
$6,394,000
Shares Out
328,731,362
Trailing EPS
$-0.05
Book Value
$-0.01
ROE
-1128.6%
ROA
-118.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,765,000 | -10,949,000 | -11,780,000 | 8,311,000 | 6,785,000 | 4,042,000 | -8,297,000 |
| Dec 2024 | 17,779,000 | -4,305,000 | -2,402,000 | 10,513,000 | 4,457,000 | 8,851,000 | -3,206,000 |
| Dec 2023 | 12,230,000 | -4,163,000 | -3,504,000 | 8,205,000 | 4,003,000 | 6,844,000 | -2,365,000 |
| Dec 2022 | 5,884,000 | -5,056,000 | -4,473,000 | 4,858,000 | 2,847,000 | 4,878,000 | -2,762,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.03
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RAPH | Raphael Pharmaceutical Inc. | $28.25M | $1.40 | — |
| MRMD | MARIMED INC. | $29.42M | $0.07 | — |
| VGAS | Verde Clean Fuels, Inc. | $25.14M | $1.14 | — |
| UG | UNITED GUARDIAN INC | $32.62M | $7.10 | — |
| BIOX | Bioceres Crop Solutions Corp. | $22.85M | $0.36 | — |
News headlines (Yahoo Finance, 1h cache)
/C O R R E C T I O N from Tũ Nipi Water Solutions Ltd./
2026-09-15 20:20 · Yahoo
BioLargo Inc (BLGO) (Q2 2026) Earnings Call Highlights: Navigating Setbacks and Building a ...
2026-09-11 11:00 · Yahoo
BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More
2026-09-10 13:00 · Yahoo
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026
2026-09-01 10:00 · Yahoo
BioLargo Equipment Solutions & Technologies' "PFAS Lady" to Teach PFAS 101 at 41st Annual Tri-State Seminar
2026-07-29 12:00 · Yahoo
BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly
2026-07-27 10:00 · Yahoo
BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
2026-07-13 14:30 · Yahoo
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets
2026-05-05 07:00 · Yahoo
BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026
2026-05-04 08:00 · Yahoo
BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology
2026-05-04 09:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.